Morgan E. Lorkowski

407 total citations
13 papers, 340 citations indexed

About

Morgan E. Lorkowski is a scholar working on Biomedical Engineering, Biomaterials and Immunology. According to data from OpenAlex, Morgan E. Lorkowski has authored 13 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biomedical Engineering, 7 papers in Biomaterials and 5 papers in Immunology. Recurrent topics in Morgan E. Lorkowski's work include Nanoparticle-Based Drug Delivery (7 papers), Nanoplatforms for cancer theranostics (6 papers) and Immunotherapy and Immune Responses (4 papers). Morgan E. Lorkowski is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), Nanoplatforms for cancer theranostics (6 papers) and Immunotherapy and Immune Responses (4 papers). Morgan E. Lorkowski collaborates with scholars based in United States and United Kingdom. Morgan E. Lorkowski's co-authors include Efstathios Karathanasis, Gil Covarrubias, Prabhani U. Atukorale, Peter A. Bielecki, Taylor J. Moon, Ketan B. Ghaghada, Pubudu M. Peiris, Shruti Raghunathan, Oguz Turan and William P. Schiemann and has published in prestigious journals such as PLoS ONE, Journal of Controlled Release and Nanoscale.

In The Last Decade

Morgan E. Lorkowski

13 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morgan E. Lorkowski United States 11 187 171 107 98 60 13 340
Laura Sanz-Ortega Spain 8 193 1.0× 159 0.9× 142 1.3× 87 0.9× 82 1.4× 13 413
Shruti Raghunathan United States 8 121 0.6× 124 0.7× 76 0.7× 79 0.8× 48 0.8× 8 268
Chandra Kumar Elechalawar United States 11 156 0.8× 154 0.9× 50 0.5× 159 1.6× 50 0.8× 12 376
Matteo Monieri Italy 10 102 0.5× 135 0.8× 46 0.4× 176 1.8× 80 1.3× 15 432
N. F. Grinenko Russia 10 132 0.7× 114 0.7× 57 0.5× 170 1.7× 70 1.2× 26 375
Jican Liu China 8 149 0.8× 225 1.3× 44 0.4× 194 2.0× 36 0.6× 12 398
Anthony Tuesca United States 8 128 0.7× 131 0.8× 49 0.5× 274 2.8× 47 0.8× 10 464
Gopikrishna Moku India 9 115 0.6× 121 0.7× 133 1.2× 225 2.3× 67 1.1× 12 375
Zakia Belhadj China 7 161 0.9× 164 1.0× 78 0.7× 285 2.9× 24 0.4× 10 492
Huajian Chen China 15 161 0.9× 97 0.6× 54 0.5× 313 3.2× 52 0.9× 23 451

Countries citing papers authored by Morgan E. Lorkowski

Since Specialization
Citations

This map shows the geographic impact of Morgan E. Lorkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morgan E. Lorkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morgan E. Lorkowski more than expected).

Fields of papers citing papers by Morgan E. Lorkowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morgan E. Lorkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morgan E. Lorkowski. The network helps show where Morgan E. Lorkowski may publish in the future.

Co-authorship network of co-authors of Morgan E. Lorkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Morgan E. Lorkowski. A scholar is included among the top collaborators of Morgan E. Lorkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morgan E. Lorkowski. Morgan E. Lorkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Moon, Taylor J., et al.. (2023). Can targeted nanoparticles distinguish cancer metastasis from inflammation?. Journal of Controlled Release. 362. 812–819. 2 indexed citations
2.
Bielecki, Peter A., Morgan E. Lorkowski, Taylor J. Moon, et al.. (2021). The effect of PEGylation on the efficacy and uptake of an immunostimulatory nanoparticle in the tumor immune microenvironment. Nanoscale Advances. 3(17). 4961–4972. 24 indexed citations
3.
Covarrubias, Gil, Morgan E. Lorkowski, Eric Abenojar, et al.. (2021). Hyperthermia-mediated changes in the tumor immune microenvironment using iron oxide nanoparticles. Nanoscale Advances. 3(20). 5890–5899. 12 indexed citations
4.
Covarrubias, Gil, Taylor J. Moon, Morgan E. Lorkowski, et al.. (2021). Comparison of the uptake of untargeted and targeted immunostimulatory nanoparticles by immune cells in the microenvironment of metastatic breast cancer. Journal of Materials Chemistry B. 10(2). 224–235. 15 indexed citations
5.
Covarrubias, Gil, Mette L. Johansen, Jason Vincent, et al.. (2020). PTPmu-targeted nanoparticles label invasive pediatric and adult glioblastoma. Nanomedicine Nanotechnology Biology and Medicine. 28. 102216–102216. 9 indexed citations
6.
Lorkowski, Morgan E., Prabhani U. Atukorale, Peter A. Bielecki, et al.. (2020). Immunostimulatory nanoparticle incorporating two immune agonists for the treatment of pancreatic tumors. Journal of Controlled Release. 330. 1095–1105. 50 indexed citations
7.
Bielecki, Peter A., Morgan E. Lorkowski, Prabhani U. Atukorale, et al.. (2020). Immunostimulatory silica nanoparticle boosts innate immunity in brain tumors. Nanoscale Horizons. 6(2). 156–167. 45 indexed citations
8.
Lorkowski, Morgan E., Prabhani U. Atukorale, Ketan B. Ghaghada, & Efstathios Karathanasis. (2020). Stimuli‐Responsive Iron Oxide Nanotheranostics: A Versatile and Powerful Approach for Cancer Therapy. Advanced Healthcare Materials. 10(5). e2001044–e2001044. 33 indexed citations
9.
Turan, Oguz, Peter A. Bielecki, Morgan E. Lorkowski, et al.. (2019). Delivery of drugs into brain tumors using multicomponent silica nanoparticles. Nanoscale. 11(24). 11910–11921. 44 indexed citations
10.
Turan, Oguz, Peter A. Bielecki, Morgan E. Lorkowski, et al.. (2019). Treatment of Glioblastoma Using Multicomponent Silica Nanoparticles. Advanced Therapeutics. 2(11). 26 indexed citations
11.
Covarrubias, Gil, Morgan E. Lorkowski, Bernadette O. Erokwu, et al.. (2018). Imaging breast cancer using a dual-ligand nanochain particle. PLoS ONE. 13(10). e0204296–e0204296. 15 indexed citations
12.
Peiris, Pubudu M., Gil Covarrubias, Shruti Raghunathan, et al.. (2018). Precise targeting of cancer metastasis using multi-ligand nanoparticles incorporating four different ligands. Nanoscale. 10(15). 6861–6871. 45 indexed citations
13.
Covarrubias, Gil, Morgan E. Lorkowski, Prabhani U. Atukorale, et al.. (2017). One-pot synthesis of nanochain particles for targeting brain tumors. Nanoscale. 9(27). 9659–9667. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026